For the Inventor, By the Inventor

Enter assignee name

Woburn, MA, United States of America

Azurity Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 52

EPO Patents = 4

Trademarks = 30

Forward Citations = 79

Loading Chart...

Loading Chart...

53 inventors (with patents filed for the assignee):

Gerold L Mosher (14 out of 66 patents)

Zeus Pendon (10 out of 11 patents)

Scott Brauer (9 out of 14 patents)

4. Peter Mione (7 out of 12 patents)

5. Anisa Gandhi (7 out of 9 patents)

6. Steven Dinh (7 out of 8 patents)

7. Hugh Greg Thomas (6 out of 10 patents)

8. Ken Fallin (5 out of 5 patents)

9. Neal Muni (5 out of 5 patents)

10. David W Miles (5 out of 26 patents)

11. Indu Muni (5 out of 20 patents)

12. Cristina LeChiara (5 out of 8 patents)

13. Sumitra Ashokkumar Pillai (5 out of 34 patents)

14. Jayanta Kumar Mandal (4 out of 51 patents)

15. Swati Nagar (4 out of 10 patents)

Core Competencies:

Clonidine

Amlodipine

Zonisamide

Nilotinib

Colon Cleansing

Omeprazole

Nimodipine

Cabozantinib

Vancomycin

Bendamustine

Metronidazole

Injection Compositions

52 patents: Sort by Forward Citations

1. 12778929 - Stable pharmaceutical compositions of Edaravone (2026-11-03),

2. 12721843 - Amlodipine formulations (2026-09-01),

3. 12721837 - Stable pharmaceutical compositions of clonidine (2026-09-01),

4. 12685723 - Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof (2026-07-21),

5. 12629369 - Pharmaceutical compositions of nilotinib (2026-05-19),

6. 12594298 - Methods of administering safe colon cleansing compositions (2026-04-07),

7. 12491179 - Oral pharmaceutical composition comprising zonisamide and process of preparation thereof (2025-12-09),

8. 12458593 - Suspensions and diluents for metronidazole and baclofen (2025-11-04),

9. 12440566 - Compositions and kits for omeprazole suspension (2025-10-14),

10. 12440474 - Stable pharmaceutical compositions of clonidine (2025-10-14),

11. 12433931 - Lisinopril formulations (2025-10-07),

12. 12419867 - Stable pharmaceutical compositions of bendamustine (2025-09-23),

13. 12403140 - Pharmaceutical compositions of nilotinib (2025-09-02),

14. 12383498 - Amlodipine formulations (2025-08-12),

15. 12383491 - Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate (2025-08-12),

Company Overview

Azurity Pharmaceuticals, Inc., based in Woburn, MA, specializes in the development and manufacturing of pharmaceutical compositions. The company focuses on innovative formulations of established medications, including clonidine, amlodipine, zonisamide, and nilotinib, among others. Azurity is dedicated to addressing unmet medical needs through its expertise in drug delivery and formulation science, particularly in areas such as colon cleansing and gastrointestinal health, enhancing patient outcomes with tailored therapeutic solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

52 Patents

#9 in Woburn, MA

#384 in Massachusetts

#6,782 in US

#13,591 in the World

Woburn, MA, United States of America

Azurity Pharmaceuticals, Inc.

Forward Citations = 79

53 inventors:

Gerold L Mosher (14 out of 66 patents)

Zeus Pendon (10 out of 11 patents)

Scott Brauer (9 out of 14 patents)

4. Peter Mione (7 out of 12 patents)

5. Anisa Gandhi (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Azurity Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/azurity-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…